Full Press Release Details
eylea hd aflibercept approved by fda as first and only injectable anti vegf with dosing intervals up to 5 months for wet age related macular degeneration wamd and diabetic macular.
REGN
eylea hd aflibercept approved by fda as first and only injectable anti vegf with dosing intervals up to 5 months for wet age related macular degeneration wamd and diabetic macular
Key Takeaway: eylea hd aflibercept approved by fda as first and only injectable anti vegf with dosing intervals up to 5 months for wet age related macular degeneration wamd and diabetic macular